SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Arthur Klausner to be a panelist at the 12th Annual Drug Delivery Partnerships Conference in San Diego, CA
News | 01. 21. 2008
